Related Experiment Video
Updated: May 6, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.7K
[Management of gestational diabetes]
J C Philips1, P Emonts, A Pintiaux
1Service de Diabétologie, Nutrition et Maladies métaboliques, CHU de Liège. jcphilips@chu.ulg.ac.be
Revue Medicale De Liege
|November 5, 2013
Summary
Gestational diabetes mellitus (GDM) affects pregnancies, increasing risks for mother and baby. Early screening and management, including lifestyle changes and medication, improve outcomes and reduce future type 2 diabetes risk.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Public Health
Background:
- Pregnancy naturally induces insulin resistance and carbohydrate intolerance.
- Gestational diabetes mellitus (GDM) is a significant risk factor for adverse pregnancy outcomes.
- GDM screening and management are recommended for all pregnant women.
Observation:
- GDM prevalence varies (1-25%) based on ethnicity and diagnostic criteria.
- Interventions like lifestyle changes and medication improve perinatal outcomes.
- Women with GDM have a high risk of developing type 2 diabetes postpartum.
Findings:
- Early detection and intervention in GDM are crucial for maternal and fetal health.
- Effective management strategies include lifestyle modification, oral medications, and insulin therapy.
- Postpartum health behaviors are vital for women previously diagnosed with GDM.
Implications:
- Optimizing GDM management can reduce immediate pregnancy complications.
- Long-term health strategies for GDM patients are essential to prevent type 2 diabetes.
- Standardized screening and treatment protocols enhance GDM care globally.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
5.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Pathophysiology of Diabetes
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Diabetes Mellitus: Introduction
57
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
57
Hyperglycemia
35
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
35

